Bile fibronectin in biliary stricture diagnosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2006 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/1846 |
Resumo: | Background: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures. |
id |
INCA-1_08cc1e2d7a24a044173460e9d205013f |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/1846 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Bile fibronectin in biliary stricture diagnosisFibronectina biliar no diagnóstico de estenoses biliaresBilePancreatocolangiografiaFibronectinaIcteríciaBileCholangiopancreatographyFibronectinJaundiceBackground: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures.Introdução: Ainda, não existe método ideal para o diagnóstico diferencial entre estenoses biliares malignas e benignas. Este estudo visa a comparar a concentração de fibronectina biliar nos pacientes com e sem estenose biliar maligna. Métodos: Durante a pancreatocolangiografia retrógrada endoscópica (PCRE), foram coletadas amostras de bile de 50 pacientes com estenose biliar extra-hepática maligna (40), benigna (10) e de 10 doentes sem estenose biliar (grupo controle). A fibronectina total na bile foi determinada por ensaio imunoenzimático. A concentração sérica de bilirrubina direta, fosfatase alcalina, gama glutamiltransferase, aspartato aminotransferase e alanina aminotransferase foi determinada nos pacientes com estenose biliar antes da PCRE. O diagnóstico final foi definido por cirurgia, biópsia ou acompanhamento clínico. Resultados: Os pacientes com neoplasia maligna eram significativamente mais idosos (p= 0,02) e apresentaram níveis mais elevados dos testes bioquímicos relacionados à colestase (p< 0,01). Não houve diferença significativa na concentração de fibronectina biliar entre os pacientes com estenose maligna (694,2 ± 823,5 ng/ml), benigna (828,9 ± 925ng/ml) e grupo controle (466,5 ± 621,5 ng/ml), ou entre os pacientes com (721,2 ± 836,6 ng/ml) e sem estenose (466,5 ± 621,5 ng/ml). Conclusões: As médias de idade e de resultados de exames laboratoriais relacionados à colestase foram mais elevadas nos pacientes com neoplasia maligna. A dosagem apenas da fibronectina total na bile não foi eficaz para diagnóstico diferencial das estenoses biliares.INCA2006-12-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/184610.32635/2176-9745.RBC.2006v52n4.1846Revista Brasileira de Cancerologia; Vol. 52 No. 4 (2006): Oct.Nov./Dec.; 331-335Revista Brasileira de Cancerologia; Vol. 52 Núm. 4 (2006): oct./nov./dic.; 331-335Revista Brasileira de Cancerologia; v. 52 n. 4 (2006): out./nov./dez.; 331-3352176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/1846/1121Ornellas, Laura Cotta Nakao, Frank Shigueo Rohr, Maria Rachel da Silveira Leite-Mor, Marilisa Moraes Barros Parise, Edison Ferrari, Angelo Paulo info:eu-repo/semantics/openAccess2021-11-29T20:27:27Zoai:rbc.inca.gov.br:article/1846Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:27:27Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Bile fibronectin in biliary stricture diagnosis Fibronectina biliar no diagnóstico de estenoses biliares |
title |
Bile fibronectin in biliary stricture diagnosis |
spellingShingle |
Bile fibronectin in biliary stricture diagnosis Ornellas, Laura Cotta Bile Pancreatocolangiografia Fibronectina Icterícia Bile Cholangiopancreatography Fibronectin Jaundice |
title_short |
Bile fibronectin in biliary stricture diagnosis |
title_full |
Bile fibronectin in biliary stricture diagnosis |
title_fullStr |
Bile fibronectin in biliary stricture diagnosis |
title_full_unstemmed |
Bile fibronectin in biliary stricture diagnosis |
title_sort |
Bile fibronectin in biliary stricture diagnosis |
author |
Ornellas, Laura Cotta |
author_facet |
Ornellas, Laura Cotta Nakao, Frank Shigueo Rohr, Maria Rachel da Silveira Leite-Mor, Marilisa Moraes Barros Parise, Edison Ferrari, Angelo Paulo |
author_role |
author |
author2 |
Nakao, Frank Shigueo Rohr, Maria Rachel da Silveira Leite-Mor, Marilisa Moraes Barros Parise, Edison Ferrari, Angelo Paulo |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Ornellas, Laura Cotta Nakao, Frank Shigueo Rohr, Maria Rachel da Silveira Leite-Mor, Marilisa Moraes Barros Parise, Edison Ferrari, Angelo Paulo |
dc.subject.por.fl_str_mv |
Bile Pancreatocolangiografia Fibronectina Icterícia Bile Cholangiopancreatography Fibronectin Jaundice |
topic |
Bile Pancreatocolangiografia Fibronectina Icterícia Bile Cholangiopancreatography Fibronectin Jaundice |
description |
Background: The methods currently available for differential diagnosis between benign and malignant biliary strictures are suboptimal. This study aimed to compare bile fibronectin levels in patients with malignant biliary stricture, benign stricture, and those without obstructive lesions. Methods: Bile samples were collected in 50 patients with malignant (40) and benign (10) extra-hepatic biliary stricture and 10 patients without biliary stricture (control group) during endoscopic retrograde cholangiopancreatography (ERCP). Total bile fibronectin was determined by enzymatic immunoassay. Direct bilirubin, alkaline phosphatase, gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase serum levels were determined in patients with biliary stricture before ERCP. Final diagnosis was established by surgery, biopsy, or follow-up. Results: Patients with malignant neoplasia were significantly older (p= 0.02) and had higher levels of biochemical tests related to cholestasis (p< 0.01). There was no significant difference in bile fibronectin level between patients with malignant stricture (694.2 ± 823.5ng/ml), benign stricture (828.9 ± 925ng/ml), and controls (466.5 ± 621.5 ng/ml), or between patients with (721.2 ± 836.6 ng/ml) and without stricture (466.5 ± 621.5 ng/ml). Conclusions: Mean age and laboratory levels related to cholestasis were higher in patients with malignant neoplasia. Isolated determination of total bile fibronectin was not efficient for the differential diagnosis of biliary strictures. |
publishDate |
2006 |
dc.date.none.fl_str_mv |
2006-12-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/1846 10.32635/2176-9745.RBC.2006v52n4.1846 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/1846 |
identifier_str_mv |
10.32635/2176-9745.RBC.2006v52n4.1846 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/1846/1121 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 52 No. 4 (2006): Oct.Nov./Dec.; 331-335 Revista Brasileira de Cancerologia; Vol. 52 Núm. 4 (2006): oct./nov./dic.; 331-335 Revista Brasileira de Cancerologia; v. 52 n. 4 (2006): out./nov./dez.; 331-335 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042248187117568 |